Human Error in GMP: From Investigation to Prevention (2)

In pharmaceutical operations, human error is a major regulatory concern, as it often reveals weaknesses in systems, processes, and work practices rather than isolated individual failures. Repeatedly, global regulators cite “human error” observations as indicators of poor system design, ineffective controls, and inadequate oversight.  To support organizations in addressing these expectations, INOPHAR Consulting & Training invites you to an advanced, practice-oriented workshop:  “Human Error in GMP: From Investigation to Prevention.”

This program is meticulously designed for professionals in Quality Assurance, Quality Control, Production, Engineering, Tech Transfer, R&D, and Regulatory affairs. 

What participants will gain:

• Predict and manage human error through better system and process design

• Strengthen investigations using regulator-aligned frameworks and robust CAPAs